Company Name
Shanghai Yaxin Biotechnology Limited Company
Year of Establishment
2008
Annual Turnover(USD)
less than 500,000
Company Introduction
Shanghai Yaxin Biotechnology Co., Ltd. was established in 2008, a high-tech enterprise underChina National Biotec Group Company Limited (CNBG) of China National PharmaceuticalGroup Co., Ltd.(Sinopharm), focusing on R&D and production of animal-free sourced biopharmaceutical enzymes. lt is one of the drafters and formulators of the "Recombinant Trypsin Standard" of the 2020 edition of “Chinese Pharmacopoeia", and supplier of key rawmaterials in biomedicine market in China.
Main Competitive Advantages
International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Small Orders Accepted,Reputation,Quality Service,
Website
http://www.yaxinbio.com
Other Competitive Advantages
Recombinant Products; Animal component-free of high purity, convenience and safety